Combining cetuximab with killer lymphocytes synergistically inhibits human cholangiocarcinoma cells in vitro

Takashi Morisaki, Masayo Umebayashi, Akifumi Kiyota, Norihiro Koya, Hiroto Tanaka, Hideya Onishi, Mitsuo Katano

Research output: Contribution to journalArticlepeer-review

24 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Combining cetuximab with killer lymphocytes synergistically inhibits human cholangiocarcinoma cells in vitro'. Together they form a unique fingerprint.

Medicine & Life Sciences